Skip to main content
. Author manuscript; available in PMC: 2020 Feb 18.
Published in final edited form as: Thromb Haemost. 2018 Jun 30;118(8):1450–1460. doi: 10.1055/s-0038-1661353

Figure 6. Targeting plasma Fn-EDA with anti-Fn-EDA Ig after reperfusion significantly reduces infarct size.

Figure 6.

A. The left panels show representative 2, 3, 5-triphenyl-tetrazolium chloride stained serial heart sections from control and anti-Fn-EDA Ig treated Apoe−/− male mice. The right panel shows quantification (N=9-11 mice/group). B. cTnI levels as assessed before sacrifice at 24 hours. Data are mean ± SEM. Statistical analysis: unpaired Student’s t-test.